Matthew Mosior
ORCID: 0000-0002-9704-408XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma”.
Brian Hess, Veronika Bachanová, Nancy L. Bartlett, Melissa M. Berrien-Elliott, Ethan McClain +21 more
Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker‐Hapak, Amanda F. Cashen +15 more
Bryan Fisk, Joshua F. McMichael, Matthew Mosior, Jennifer A. Foltz, Zachary L. Skidmore +26 more
Matthew Mosior, Joshua McMichael, Zachary L. Skidmore, Eric J. Duncavage, Christopher A. Miller +24 more
Timothy H.-P. Chen, Bryan Fisk, Haolin Shen, Matthew Mosior, Zachary L. Skidmore +6 more
Kilannin Krysiak, Cody A. Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez +18 more
Timothy H.-P. Chen, Bryan Fisk, Haolin Shen, Matthew Mosior, Zachary L. Skidmore +6 more